Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 5Other 2Gynecologic 2

Conditions

Ovarian Neoplasms 1423Uterine Cervical Neoplasms 926Endometrial Neoplasms 493Carcinoma, Ovarian Epithelial 426Breast Neoplasms 425Fallopian Tube Neoplasms 413Neoplasms 274Uterine Cervical Dysplasia 208Colorectal Neoplasms 170Carcinoma, Non-Small-Cell Lung 168Pancreatic Neoplasms 156Prostatic Neoplasms 153Lung Neoplasms 151Stomach Neoplasms 126Peritoneal Neoplasms 119Sarcoma 117Uterine Neoplasms 112Melanoma 111Urinary Bladder Neoplasms 108Papillomavirus Infections 107Colonic Neoplasms 106Head and Neck Neoplasms 105Vulvar Neoplasms 101Esophageal Neoplasms 100Recurrence 95Testicular Neoplasms 91Carcinoma, Renal Cell 89Vaginal Neoplasms 79Small Cell Lung Carcinoma 77Kidney Neoplasms 74

Interventions

Laser Therapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Dyspareunia × Gynecologic × Clear all
NCT03307044 2023-03-20

Fractional CO2 Laser Therapy for Survivors of Breast Malignancies

Ohio State University Comprehensive Cancer Center

Phase NA Completed
66 enrolled
BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Dyspareunia

NCT03372720 2022-04-22

Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors

Ohio State University Comprehensive Cancer Center

Phase NA Completed
19 enrolled
Gynecologic

Uterine Cervical Neoplasms, Dyspareunia, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡